Banco de Sabadell S.A (SAB)
Madrid Stock Exchange · Spain · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 3.550 |
|---|---|
| 52-week range | 2.788 – 3.770 |
| Return, 1 month / 3 months | −5.5% / +4.0% |
| Return, 1 year / 3 years | +35.0% / +333.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 49 |
| Volatility (1 year) | 26.8% |
| Worst drawdown (1 year) | -13.7% |
| Average daily value traded | 53.15M EUR |
| Dividend yield | 16.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Banco de Sabadell is a Spanish commercial bank based in Sabadell, Catalonia. It takes deposits and provides loans, mortgages, current accounts, payment cards and insurance to individual customers, self-employed people, small and medium-sized enterprises and larger corporate clients. Much of its branch network and customer base sits in Spain, and it also runs banking operations in other European markets and serves business customers with trade and treasury services.
The shares are listed on the Madrid Stock Exchange in Spain under the code SAB, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Banco de Sabadell S.A (SAB) trades on the Madrid Stock Exchange in Spain. It last closed at EUR 3.550 on 27 October 2026.
Its price-based Market X-Ray is 80 out of 100 (a strong price profile), ranking 7 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 35.0% and over the last three months it rose 4.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.7% | ||
| From 52-week high | -5.5% | ||
| Momentum | 90 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 4.0% | ||
| 6-month return | 30.9% | ||
| 12-month return, skipping the last month | 42.8% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.7% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 53.15M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 73 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 16.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.3% |
|---|---|
| 1 month | −5.5% |
| 3 months | +4.0% |
| 6 months | +30.9% |
| 1 year | +35.0% |
| 3 years | +333.6% |
| 5 years | +720.2% |
Signals
| 50-day / 200-day average | 3.625 / 3.096 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.084 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 May 2026 | EUR 0.5000 |
| 23 Dec 2025 | EUR 0.0700 |
| 27 Aug 2025 | EUR 0.0700 |
| 26 Mar 2025 | EUR 0.1244 |
| 27 Sep 2024 | EUR 0.0800 |
| 16 Apr 2024 | EUR 0.0300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.